EMA publishes From laboratory to patient: the journey of a centrally authorised medicine

The European Medicines Agency (EMA) has recently published a booklet covering the process undertaken for medicines for human use and which are authorised through the EU centralised procedure. With a user-friendly layout, it communicates the steps that are taken from the initial research stages of a new medicine to when it is eventually marketed to the public.
The convenient and accessible manual explains how the EMA provides scientific advice to support the timely and sound development of high-quality, effective and safe medicines, for the benefit of patients. Read the booklet in full here